New facility is a game changer for medical technology in Shreveport


BRF is opening a new Center for Molecular Imaging and Therapy.  Governor John Bel Edwards in town for the groundbreaking of the new $14 million medical facility.

To secure the CMIT project, the State of Louisiana offered BRF a competitive incentive package that
consists of a $1 million performance based grant. The grant will offset the costs of medical equipment
and building expenses associated with the project.

Friday’s demolition ceremony involving local and state government officials at the new site at the corner of Kings Highway and Mansfield Road in Shreveport marked the groundbreaking.

The new facility will house radiopharmaceutical production equipment and operations, patient imaging services, and a clinical and translational research program.

CMIT is led by Executive Director Pradeep K. Garg, Ph.D., who has an extensive background in molecular imaging research and in developing disease specific novel radiopharmaceuticals.  The program Dr. Garg will lead is the evolution of BRF’s PET Imaging Center, the first molecular imaging
scanning and radiopharmaceutical production facility in the state, which opened in 1995. The center was one of the nation’s first full service, nonacademic centers and grew into one of the most active centers in the South, serving over 46,000 patients.

“BRF has been an innovator and will continue to be a leader in the field of molecular imaging
and research,” said Gov. John Bel Edwards. “Access to this technology is vitally important for Louisiana and this region. This expanded program will increase research collaboration opportunities for our
universities and the LSU School of Medicine in Shreveport, ensure access to cutting edge diagnostic and therapeutic care for patients, and extend investment in the biomedical and healthcare economies in the Shreveport Healthcare and Development Corridor.”

With new production equipment and expanded capabilities, CMIT will grow its catalog of novel
radiopharmaceuticals to include applications in cardiovascular disease, prostate cancer, Alzheimer’s
disease and related dementias, hyperinsulinism, and pancreatic and other cancers.

According to a 2014 study by Tripp Umbach, by 2020, there will be roughly 30,000 direct and indirect
employees working in the Shreveport Healthcare and Development Corridor, with an estimated
economic impact of $4.9 billion per year.

“I am excited about the Center for Molecular Imaging and Therapy. This new program will have a
profound impact on our area,” said Shreveport Mayor Adrian Perkins. “The medical community is a
critical part of Northwest Louisiana’s economy. This investment in the Shreveport Healthcare and
Development Corridor brings both jobs and resources to Shreveport and it brings them to a resource
deprived area.  It grows our economy and improves healthcare in our city. It is a win for Shreveport.”

Construction of this new facility adjacent to BRF’s headquarters in the InterTech Science Park will
consolidate CMIT operations under one roof on the Shreveport Healthcare and Development

The worldwide market for novel diagnostic and therapeutic radiopharmaceuticals is expected to reach
$7.4 billion by 2024. 

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss